- Home
- PRPO vs BDRX Comparison
PRPO vs BDRX Comparison
Compare PRPO & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- BDRX
- Stock Information
- Founded
- PRPO N/A
- BDRX 2000
- Country
- PRPO United States
- BDRX United Kingdom
- Employees
- PRPO 57
- BDRX N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- PRPO Industrials
- BDRX Health Care
- Exchange
- PRPO Nasdaq
- BDRX Nasdaq
- Market Cap
- PRPO 9.5M
- BDRX 2.8M
- IPO Year
- PRPO N/A
- BDRX N/A
- Fundamental
- Price
- PRPO $6.59
- BDRX $6.15
- Analyst Decision
- PRPO
- BDRX Strong Buy
- Analyst Count
- PRPO 0
- BDRX 1
- Target Price
- PRPO N/A
- BDRX $200.00
- AVG Volume (30 Days)
- PRPO 7.9K
- BDRX 457.8K
- Earning Date
- PRPO 11-11-2024
- BDRX 10-29-2024
- Dividend Yield
- PRPO N/A
- BDRX N/A
- EPS Growth
- PRPO N/A
- BDRX N/A
- EPS
- PRPO N/A
- BDRX N/A
- Revenue
- PRPO $16,719,999.00
- BDRX $104,895.00
- Revenue This Year
- PRPO $75.18
- BDRX N/A
- Revenue Next Year
- PRPO N/A
- BDRX N/A
- P/E Ratio
- PRPO N/A
- BDRX N/A
- Revenue Growth
- PRPO 52.61
- BDRX N/A
- 52 Week Low
- PRPO $4.31
- BDRX $4.71
- 52 Week High
- PRPO $8.99
- BDRX $220.25
- Technical
- Relative Strength Index (RSI)
- PRPO 52.82
- BDRX 43.80
- Support Level
- PRPO $6.42
- BDRX $5.50
- Resistance Level
- PRPO $6.99
- BDRX $10.89
- Average True Range (ATR)
- PRPO 0.33
- BDRX 1.07
- MACD
- PRPO -0.04
- BDRX 0.32
- Stochastic Oscillator
- PRPO 69.91
- BDRX 23.30
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.